This protocol is judged by an institutional evaluation board, an unbiased team that critiques any scientific trials involving individuals. If a review consists of a Program I drug, after the board approves the protocol as moral, the researchers really need to submit an application for an investigational new drug (IND) variety from the FDA.Medicine